Overview

• Resolution 2426/2025 published in the Boletín Oficial formalizes Morán’s appointment on a temporary basis for 180 working days starting August 21 while a competitive process is organized for a permanent director.
• Morán replaces Gabriela Mantecón Fumado, who was removed after investigators found she archived a March 26 technical warning about serious irregularities at HLB Pharma and Ramallo.
• ANLIS‑Malbrán determined the manufacturing procedure for fentanyl lot 31202 was irregular; the batch, produced on December 18, 2024, has been linked in reports to 96 deaths.
• The government says the change is intended to order and reinforce INAME’s control mechanisms and to strengthen transparency, traceability and enforcement for controlled medicines.
• The criminal case remains active with at least 24 people charged and detentions that include HLB Pharma owner Ariel García Furfaro, and a confidential internal administrative review at INAME continues in parallel.